Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Targeted Plasticity Therapy for PTSD

NCT: NCT06266364 · RECRUITING

NCT IDNCT06266364
StatusRECRUITING
Start Date2024-12-30
Completion2028-06
SponsorThe University of Texas at Dallas (OTHER)
First posted
Last updated

Brief Summary

Objectives of this study are to provide continued safety assessment for the ReStore system, and to gain further estimates of the effect size of Vagus Nerve Stimulation (VNS) therapy with Prolonged Exposure Therapy (PE) compared to PE with placebo (sham) stimulation in participants with posttraumatic stress disorder (PTSD)

Frequently Asked Questions

What is Targeted Plasticity Therapy for PTSD?

Targeted Plasticity Therapy for PTSD is a clinical trial registered under NCT06266364. Current status: RECRUITING.

What is the status of NCT06266364?

The current status of NCT06266364 (Targeted Plasticity Therapy for PTSD) is: RECRUITING.

When did Targeted Plasticity Therapy for PTSD start?

Targeted Plasticity Therapy for PTSD started on 2024-12-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.